164 results
Page 2 of 9
6-K
EX-99.2
ifd3r4rpld
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
kbrwok
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.2
4o8fb88fghuly4j
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
tijvvga02xptsfw5o6yj
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99
l1o7sn5y15abnvphs
26 Jul 22
Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
1:45pm
6-K
EX-99.1
axj06c0jwlv021dy5w
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.4
jr9omit
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
asw 7vvhku
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.4
pnn36uuez5 mbv76vf4n
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
z0ngh1p
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.1
azowwf6338dmzk5zqv6l
29 Mar 22
RepliCel Announces Material Patent Milestones
12:51pm
6-K
EX-99.2
6emi6egk5r3 kqo
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.3
djcoosw lxrpzwaxy
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.2
jie 5hkm6k7hn3fvqdz
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
9eoxdd rnkfs91
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.1
9ujgn9
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.1
2z1uvgkcco81nks
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.2
h0i9yuabr4t78qe2sq9
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.1
h1zsnb25
21 Oct 21
Current report (foreign)
3:49pm